Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis - Wikidata - awgldk - TriplyDB

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

http://www.wikidata.org/entity/Q35295703

about

Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications Administration of fluconazole in children below 1 year of age.Sputum levels of fluconazole in humans.Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid.Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.Systemic antifungal agents.Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazole Fluconazole penetration in cerebral parenchyma in humans at steady state Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.New antiviral and antifungal drugs.Comparison of fluconazole and SDZ89-485 for therapy of experimental murine coccidioidomycosis.Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.Treatment of murine coccidioidal meningitis with SCH39304 Efficacy of SCH39304 and fluconazole in a murine model of disseminated coccidioidomycosis.Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques.Rapid and sensitive assay for fluconazole which uses gas chromatography with electron capture detection Fluconazole (Diflucan).Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography Treatment of experimental cryptococcosis with SCH 39304 and fluconazole.CNS pharmacokinetics of antifungal agents.Systemic Candida infections.Fluconazole. Review and situation among antifungal drugs in the treatment of opportunistic mycoses of human immuno-deficiency virus infections.Tissue penetration of antifungal agents.New antifungal agents for the systemic mycoses.Fluconazole plasma concentration measurement by liquid chromatography for drug monitoring of burn patients.Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis.Reflections on the approach to treatment of a mycologic disaster.Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing.Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid Plasma and tissue concentrations of fluconazole and their correlation to breakpoints.Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.Cutaneous cryptococcosis: treatment with oral fluconazole.Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis.First report of chronic meningitis caused by Trichosporon beigelii.Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.Cytochrome P450 epoxygenase dependence of opioid analgesia: fluconazole does not interfere with remifentanil-mediated analgesia in human subjects.

P2860

Q27025299-CA43D636-44B7-4770-A918-C834BF30C055 Q33680336-20307688-277B-480B-854E-EC4A10789555 Q33742933-7D06886D-C540-4B34-BC21-9F1EF91473AA Q33758961-9DD3A54E-33D0-4EF6-8F6B-541C94EAB96A Q34142328-0BE8A47A-24A8-4EC2-96D6-BEAFD09D2A51 Q34344425-904A9A22-FB5B-45B0-B186-F5967004A278 Q34437719-C8A372EC-5456-4CF9-A29E-2CB12B97BFD2 Q34490092-A6B82C57-143A-4449-AF81-E556624BC6A8 Q34505582-BB65A45F-317A-4D38-916C-54EDBC89FAE9 Q35112281-A11A939A-0786-42DE-B28A-5E2CD8BE1BBB Q35114601-03C077CA-8A0F-463A-85E5-6E3BE1B78FA1 Q35136738-29B5D09C-1AE5-4695-9EDD-8D50D575CE51 Q35168469-87B61684-9011-4537-B456-0FBCAD37A09E Q35245267-BD388DB5-F578-4E01-A202-9C9B5ADD337A Q35250532-80F70FC6-F2B6-40E3-BDF3-7A37B55BE570 Q35252722-046E53E7-24E6-4349-982B-B7D63D1FCCB8 Q35256048-8934FAA2-74AD-483D-878B-1BB0D9FFB170 Q35819915-A9CC183D-F7A4-40AC-93E4-64CA1935A521 Q35825795-55D6AF59-0739-408E-9ED0-E76A12E9C34C Q35867277-A15E7FD4-A519-4D18-97B2-33957E1818C5 Q36624924-D90B6F46-C4CB-4C4A-8954-9482F5716C07 Q36753682-BB21B362-60D5-428A-954B-75FF9A532CE5 Q36754260-E4D8285B-E9A8-4DB2-9FC4-8D81CC54DB55 Q36909333-2435AF93-1D0D-402A-B66D-C5D27C13A08D Q36987671-26D6B4EB-536D-43F1-91D2-6CA69795D800 Q37245969-0E64ACCA-FCF7-4D14-8930-28C6F756D51B Q37544911-0AAC96EF-2278-46FC-8D79-0FB7407AEB76 Q37876231-CF3475D8-0C27-402D-B481-95C3850923B7 Q39242940-D3721C3D-BC97-4C09-B712-EC1677CC53F0 Q39474027-7D02249E-DBEB-44D3-8A62-1DC8FC776B84 Q39767419-13327587-A4D5-4E33-83D9-B1F9424F97BA Q40286412-EBE2AB6A-1027-4001-902F-4BDBD27DD75A Q40600560-AEAEA0E5-4D06-4AC4-8DB3-AF4640601042 Q41566153-9172B55C-5914-43CE-A13B-08FC1BC7431E Q41708431-7B779A8E-5447-4B1F-B158-EFE0FC5E6745 Q41764249-0BE60EFB-C5D4-4C8B-9367-35021BCD53B2 Q42554139-B21FCF3F-5242-45A3-9AC0-5B074C95FAB8 Q44036132-BF5C4990-065F-477B-9BAF-67088571D221 Q44208502-E30D970F-811F-4F16-BC47-BFC724493163 Q44346631-F2550B08-6430-47C2-BD16-D3C0A32E1F6C

P2860

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

http://www.wikidata.org/entity/Q35295703

description

1988 nî lūn-bûn

@nan

1988 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի մարտին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Pharmacokinetics of fluconazol ...... human coccidioidal meningitis

@ast

Pharmacokinetics of fluconazol ...... human coccidioidal meningitis

@en

type

label

Pharmacokinetics of fluconazol ...... human coccidioidal meningitis

@ast

Pharmacokinetics of fluconazol ...... human coccidioidal meningitis

@en

prefLabel

Pharmacokinetics of fluconazol ...... human coccidioidal meningitis

@ast

Pharmacokinetics of fluconazol ...... human coccidioidal meningitis

@en

P1433

Q35295703-0B9A2C89-9CCB-4D2C-BF4A-9D4DA8A6DE7E

P1476

Q35295703-E59D0F0F-1F1C-4124-A6BF-31C40035C92D

P2093

Q35295703-06C91AA4-85F7-4551-9915-CB2ADC9888F8

Q35295703-2F25C000-1541-44BB-9BA2-3F39EF9E5B72

Q35295703-33E52F22-E0FA-4471-918A-010A25A95958

Q35295703-6A6A0FF0-273D-4A97-8271-A7171242B67F

Q35295703-BECD85E7-5D61-476C-AAEB-634D1FF710C3

Q35295703-BF006967-3001-446E-BC3E-D8221158E8E0

Q35295703-CD3C8BA2-D960-458D-82E5-AD724C1DD408

P2860

Q35295703-0BF51DFA-1E95-4018-913D-0AB7590BAAB5

Q35295703-35D79552-224E-4A4C-BCB0-C0373D36B49F

Q35295703-374BD4FF-0761-4B47-8296-3039CEB784BA

Q35295703-82CCF811-FD49-421B-9B19-93A2F6D53573

Q35295703-8ABADCAE-92D7-4383-B400-603CAE0C2B01

Q35295703-A6FF96EE-067B-4A93-9795-0DA08A2BF914

Q35295703-CE06BB67-50BD-4057-A083-5815C31B4FB4

P304

Q35295703-326AFF68-55BA-4399-96E1-9A48C6CA1F3E

P31

Q35295703-1D75D4FB-1EA7-4CEC-9E6E-19CB8B3D55F6

P356

Q35295703-D3A253D5-97AE-4052-951D-8A4C8DDCCE4E

P407

Q35295703-01EBD6E8-3158-4A95-95E8-D1B775D2FBEE

P433

Q35295703-3131159F-48C8-4CF7-B32E-723461A18717

P478

Q35295703-76F17ABD-FACE-4E48-B450-E050E7FC082F

P577

Q35295703-AFA9191D-C466-42CA-B1FA-27666984C2EA

P698

Q35295703-E848F7E5-2AD3-4208-903C-E9922BCD18F4

P921

Q35295703-2C21BD58-6485-486A-87F0-FE028FAD3BBD

Q35295703-4EA1AD6C-3ABA-4590-9A92-256BB532063C

P932

Q35295703-9A907AE6-5D9E-4463-AD80-546344419AB4

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pharmacokinetics of fluconazol ...... human coccidioidal meningitis

@en

P2093

Arathoon EG

http://www.w3.org/2001/XMLSchema#string

Hanson LH

http://www.w3.org/2001/XMLSchema#string

Hartstein AI

http://www.w3.org/2001/XMLSchema#string

Levine BE

http://www.w3.org/2001/XMLSchema#string

Stevens DA

http://www.w3.org/2001/XMLSchema#string

Tucker RM

http://www.w3.org/2001/XMLSchema#string

Williams PL

http://www.w3.org/2001/XMLSchema#string

P2860

Disposition of ketoconazole, an oral antifungal, in humans

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans.

Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.

Miconazole in the treatment of coccidioidomycosis.

Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport proteins

Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).

Ketoconazole blocks adrenal steroid synthesis.

P304

369-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.32.3.369

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

1988-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2835002

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

172178

http://www.w3.org/2001/XMLSchema#string